The drug, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, did not meet the primary endpoint of a ≥ 1-stage histologic improvement in fibrosis without worsening of NASH in the STELLAR-4 ...
In conclusion, pentoxifylline leads to a significant reduction in the AST and ALT levels in patients with NASH. This improvement ... inflammation and fibrosis stage. Randomized controlled trials ...
Detailed price information for Akero Therapeutics Inc (AKRO-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback